Fast-track diagnosis pathway for giant cell arteritis
Evaluates how well a quick diagnosis pathway works for people with giant cell arteritis.
Key facts
- Who runs it
- Groupe Hospitalier de la Rochelle Ré Aunis
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 14 Feb 2025
- Expected to end
- 31 Mar 2027
- Type of study
- Observational
- Record updated
- 20 June 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 50 or older whose doctors suspect giant cell arteritis. This is an inflammation of the artery walls. The trial studies a fast pathway for diagnosing it.
- Age
- 50 Years and older
- Sex
- All sexes
- Disease stage
- Suspected giant cell arteritis. The study group description lists at least one sign: eye or vision problems, recent headaches under 4 months, jaw pain when chewing, a tender scalp, fever, anemia, polymyalgia rheumatica, or a suggestive scan.
- Biomarker or test result
- The study group description lists elevated C-reactive protein ≥ 10 mg/l as one of the possible signs.
Main reasons for not taking part
- People who object to the use of their data cannot join.
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Patient suspected of GCA
Who cannot take part
- Opposition to the use of their data
This trial is currently available in France.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Giant cell arteritis is a vasculitis, i.e. inflammation of the artery walls, which generally affects people over the age of 50. Diagnosis can be long and difficult, as the clinical signs are not specific (headache, pain in the jaw, scalp, shoulders and/or pelvis, abdominal pain, weight loss, etc.), but it must be made quickly, given the risk of complications.
Read full original descriptionShow less
The reference method for diagnosis was initially based on clinical suspicion and analysis of a "piece of temporal artery" (biopsy) performed in the operating theatre under local anaesthetic. Since the mid-1990s, improvements in ultrasound techniques have made it possible to identify a sign, known as a halo, on the temporal arteries that is typical of patients with Giant Cell Arteritis. A prospective multicenter study published in 2024 demonstrated that, in patients with a clinical suspicion of Giant Cell Arteritis, if a halo was found on both temporal arteries by ultrasound, there was no need for a biopsy. This study is at the origin of a change in practices in the diagnosis and care of patients suffering from this disabling disease.
To facilitate early diagnosis, a fast-track pathway has been set up. The aim is to make a rapid diagnosis, thereby reducing the risk of after-effects, shortening the length of hospital stays, considering outpatient treatment and limiting the number of biopsies.
The investigators propose to evaluate the performance of this fast-track pathway.
The group in the trial
- Patient suspected of Giant Cell Arteritis
Patient over 50 years old suspected of Giant Cell Arteritis and presenting at least one of the following signs: Visual symptoms * Transient vision loss (amaurosis) * Anterior or posterior ischemic optic neuropathy * Occlusion of the central retinal artery and/or its branches * Diplopia due to paralysis of the oculomotor muscles * Ocular ischemic syndrome Suggestive signs and symptoms: * Recent headaches \< 4 months * Jaw claudication * Scalp tenderness * Abnormal temporal artery examination - beaded appearance, prominence, widening, tenderness * Elevated C-reactive protein ≥ 10 mg/l Systemic symptoms: * Fever * Anemia * Upper limb claudication * Polymyalgia rheumatica Suggestive imaging result * Positive positron emission computed tomography scan * CT scan aortitis
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis
- Plain-language title
- Fast-track diagnosis pathway for giant cell arteritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 20 June 2025